Literature DB >> 7372374

Inhibition of effector cell functions in natural killer cell activity (NK) and antibody-dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera.

P N Nair, G Fernandes, K Onoe, N K Day, R A Good.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7372374     DOI: 10.1002/ijc.2910250518

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  6 in total

1.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

2.  Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.

Authors:  C D Gregory; H Lee; G B Rees; I V Scott; L P Shah; P R Golding
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

3.  Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease.

Authors:  S Gupta; G Fernandes
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

4.  Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biology.

Authors:  D F Tucker; R A Knight; P H Warne
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

5.  Cellular immune function study in an ovarian cancer-prone kindred.

Authors:  G S Schuelke; H T Lynch; J F Lynch; E A Chaperon; J A Recabaren; B Grabner; W A Albano
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

6.  Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity.

Authors:  G A Bishop; J C Glorioso; S A Schwartz
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.